Greek study tracks Real-World use of potassium drug in kidney and heart patients
NCT ID NCT06185660
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study in Greece observed 125 patients with chronic kidney disease (on or off dialysis) or heart failure who were taking sodium zirconium cyclosilicate for high potassium levels. Researchers collected data on patient characteristics and treatment patterns over six months. The goal was to understand how the drug is used in everyday clinical practice, not to test its effectiveness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
sodium zirconium cyclosilicate
What this could lead to
If successful, this study could provide insights into how best to manage high potassium levels in patients with kidney or heart conditions.
What could go wrong
This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may not apply to other countries or populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Alexandroupoli, 68100, Greece
-
Research Site
Athens, 10676, Greece
-
Research Site
Athens, 11527, Greece
-
Research Site
Athens, 12462, Greece
-
Research Site
Athens, 15123, Greece
-
Research Site
Heraklion, 71500, Greece
-
Research Site
Larissa, 41110, Greece
-
Research Site
Pátrai, 26504, Greece
-
Research Site
Thessaloniki, 54636, Greece
-
Research Site
Thessaloniki, 57010, Greece